Abbott’s Q2 sales reach $12.6 billions, beating expectations

Glonghui, July 16 — Abbott reported second quarter sales of $12.6 billion, exceeding the IBES forecast of $12.5 billion; adjusted earnings per share for the second quarter were $1.31, higher than the IBES forecast of $1.28. Abbott expects sales growth of 6.5% to 7.5% for this fiscal year; adjusted earnings per share are projected to be $5.45 to $5.60, compared to the IBES estimate of $5.49. Revenue for fiscal year 2026 is expected to be $50.11 billion.